🌐 Replimune

organization

Replimune is a clinical-stage biotechnology company developing oncolytic immunotherapy treatments for cancer that may be subject to monitoring by global intelligence agencies due to its sensitive medical research and intellectual property.

13
Signals
10
Articles

Linked Signals

SignalStatusLensRoleConfidenceLast Seen
Canetas emagrecedoras fazem crescer buscas por alfaiates e brechós nos EUA com americanos encurtando cintos e remodelando calçados expired Health responder 100%
UAE shuts down all Umm Al Quwain beaches expired Health responder 100%
USC suspends LB for hit on Oregon's Dante Moore expired Health responder 100%
Soule remains at risk, Roma to evaluate offers expired Deals involved 100%
Dr Reddy's CEO On Clogged Semaglutide Pipeline expired Health involved 94%
FCC votes to toughen rules in bid to better protect undersea cables expired AI & Tech involved 100%
WSJ: US weighs shifting some Gulf military bases to Israel after Iran strikes expired Real Estate involved 100%
Antares gets $105M from Novartis for new cancer drugs expired Health involved 78%
uniQure stock surges 20% on Replimune FDA BLA news expired Health responder 88%
STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs expired Health involved 100%
U.S. Army buys more Israeli SMASH counter-drone rifle system expired Deals involved 100%
Tourette's And OCD Overlap, And a Newly Discovered Brain Link May Explain Why expired Health involved 100%
California researchers devise treatment for deadly pregnancy condition expired Health involved 100%